Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology

International Journal of Pharmaceutics

Volumn 454, Issue 1, 2013, Pages 354-366

  Zhang, Wenji ^a   Li, Xuedong ^b   Ye, Tiantian ^a   Chen, Fen ^a   Sun, Xiao ^a   Kong, Jun ^b   Yang, Xinggang ^a   Pan, Weisan ^a   Li, Sanming ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cellular uptake; Central composite design; Genistein; Inhibition; Nanostructured lipid carrier; Posterior capsular opacification

Indexed keywords

GELUCIRE; GELUCIRE 14; GELUCIRE 44; GENISTEIN; GLYCEROL BEHENATE; LIPOSOME; MIGLYOL; NANOMATERIAL; NANOSTRUCTURED LIPID CARRIER; SURFACTANT; UNCLASSIFIED DRUG;

AFTERCATARACT; ARTICLE; CAPSULE OPACIFICATION; CELL GROWTH; CELL VIABILITY; DISPERSION; DRUG ANALYSIS; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG SOLUBILITY; DRUG STABILITY; DRUG UPTAKE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INDEPENDENT VARIABLE; NANOENCAPSULATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; POSTERIOR CAPSULAR OPACIFICATION; PRIORITY JOURNAL; RESPONSE SURFACE METHOD; ROOM TEMPERATURE; SURFACE CHARGE; SURGERY; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

EID: 84884163467     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.07.032     Document Type: Article

References (42)

1. Abdelbary, G., 2011. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm. Dev. Technol. 16, 44-56.
2. Abdelbary, G., Haider, M., 2011. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate. Pharm. Dev. Technol. 10, 1-10.
3. Anderson, J.J.B., Ambrose, W.W., Garner, S.C., 1998. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc. Soc. Exp. Biol. Med. 217, 345-350.
4. Arora, A., Nair, M.G., Strasburga, G.M., 1998. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch. Biochem. Biophys. 356, 133-141. (Pubitemid 28387717)
5. Bretton, R.H., Swearingen, A., Kash, R.L., Cooley, R., 1999. Use of a polylysine-saporin conjugate to prevent posterior capsule opacification. J. Cataract Refract. Surg. 25, 921-929. (Pubitemid 29309788)
6. Freitas, C., Muller, R.H., 1998. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLNTM) dispersions. Int. J. Pharm. 168, 221-229. (Pubitemid 28349963)
7. Coon, J.S., Knudson, W., Clodfelter, K., Lu, B., Weinstein, R.S., 1990. Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. Cancer Res. 51, 897-902.
8. Spalton, D.J., 1999. Posterior capsular opacification after cataract surgery. Nature 13, 489-492. (Pubitemid 29341253)
9. Bozukova, D., Pagnoulle, C., Jerome, R., Jerome, C., 2010. Polymers in modern ophthalmic implants-historical background and recent advances. Mater. Sci. Eng. Rep. 69, 63-83.
10. 2. J. Eur. Ceram. Soc. 32, 235-244.
11. Dorr, R.T., 1994. Pharmacology and toxicology of Cremophor EL diluent. Ann. Pharmacother. 28, S11-S14. (Pubitemid 24139914)
12. Feng, S., Huang, G., 2001. Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers. J. Control Release 71, 53-69. (Pubitemid 32195441)
13. Gabriela, D.V., Laura, H., Alcira, B., et al., 2008. Characterisation of liposomes containing aminolevulinic acid and derived esters. J Photochem Photobiol. 92, 1-9.
14. Geissler, F.T., Li, D.W., James, E.R., 2001. Inhibition of lens epithelial cell growth by induction of apoptosis: potential for prevention of posterior capsule opacification. J. Ocul. Pharmacol. Ther. 17, 587-596. (Pubitemid 34019986)
15. Gelderblom, H., Verweij, J., Nooter, K., Sparreboom, A., 2001. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 37, 1590-1598. (Pubitemid 32778603)
16. Gonzalez-Mira, E., Egea, M.A., Garcia, M.L., Souto, E.B., 2010. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf. B 81, 412-421.
17. Greenwood, R., Kendall, K., 1999. Selection of suitable dispersants for aqueous suspensions of zirconia and titania powders using acoustophoresis. J. Eur. Ceram. Soc. 19, 479-488.
18. Hamada, T., Matsumoto, M., 1980. The role of vitamin E in preventing the hemolysis of kid and chick erythrocytes with Tween 20. Cell. Mol. Life Sci. 36, 978-979. (Pubitemid 11230402)
19. Honoré, E.K., Williams, J.K., Anthony, M.S., Clarkson, T.B., 1997. Soy isofiavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil. Steril. 67, 148-154. (Pubitemid 26428429)
20. Hu, F.-Q., Jiang, S.-P., Du, Y.-Z., et al., 2005. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf. B 45, 167-173. (Pubitemid 41415646)
21. Jumaa, M., Kleinebudde, P., Muller, B.W., 1999. Physicochemical properties and hemolytic effect of different lipid emulsion formulations using a mixture of emulsifiers. Pharm. Acta Helv. 73, 293-301. (Pubitemid 29324994)
22. Kim, S.-Y., Kim, J.-H., Choi, J.-S., Joo, C.-K., 2007. Comparison of posterior capsule opacification in rabbits receiving either mitomycin-C or distilled water for sealed-capsule irrigation during cataract surgery. Clin. Exp. Ophthalmol 35, 755-758. (Pubitemid 350090535)
23. Kwon, S.H., Kim, S.Y., Ha, K.W., et al., 2007. Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery. Arch. Pharm. Res. 30, 1138-1143.
24. Legler, U.F., Apple, D.J., Assia, E.I., Bluestein, E.C., Castaneda, V.E., Mowbray, S.L., 1993. Inhibition of posterior capsule opacification: the effect of colchicine in a sustained drug delivery system. J. Cataract Refract. Surg. 19, 462-470.
25. Li, X., Nie, S.-F., Kong, J., et al., 2008. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int. J. Pharm. 363, 177-182.
26. Luo, Q., Zhao, J., Zhang, X., Pan, W., 2011. Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int. J. Pharm. 403, 185-191.
27. Motlekar, N., Khan, M.A., Youan, B.-B.C., 2005. Preparation and characterization of genistein containing poly(ethylene glycol) microparticles. J. Appl. Polym. Sci. 101, 2070-2078.
28. Müller, R.H., Radtke, M., Wissing, S.A., 2002. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. 54, S131-S155. (Pubitemid 35379959)
29. Potter, S.M., Baum, J.A., Teng, H., Stillman, R.J., Shay, N.F., Erdman, J.W., 1998. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr. 68, 1375S-1379S. (Pubitemid 28550915)
30. Roberts, J.E., Wielgus, A.R., Boyes, W.K., et al., 2008. Phototoxicity and cytotoxicity of fullerol in human lens epithelial cells. Toxicol. Appl. Pharm. 228, 49-58.
31. Sarkar, F.H., Li, Y., 2002. Mechanisms of cancer chemoprevention by soy isoflavone Genistein. Cancer Metast. Rev. 21, 265-280. (Pubitemid 36071914)
32. Schoenwald, R.D., Stewart, P., 1980. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits. J. Pharm. Sci. 69, 391-394. (Pubitemid 10079746)
33. Souto, E.B., Wissing, S.A., Barbosa, C.M., Müller, R.H., 2004. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur. J. Pharm. Biopharm. 58, 83-90. (Pubitemid 38781008)
34. Szebeni, J., Alving, C.R., Muggia, F.M., 1998. Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J. Natl. Cancer Inst. 90, 300-306. (Pubitemid 28182386)
35. Tahara, K., Sakai, T., Yamamoto, H., et al., 2009. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int. J. Pharm. 382, 198-204.
36. Tian, B., Luo, Q., Song, S., et al., 2011. Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery. J. Pharm. Sci. 101, 1040-1049.
37. Tiyaboonchai, W., Tungpradit, W., Plianbangchang, P., 2007. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 337, 299-306. (Pubitemid 46756048)
38. Walker, J.L., Wolff, I.M., Zhang, L., Menko, A.S., 2007. Activation of SRC kinase signals induction of Posterior capsular opacification. Invest. Ophthalmol. Vis. Sci. 48, 2214-2223. (Pubitemid 351261297)
39. Waugh, W.N., Trissel, L.A., Stella, V.J., 1991. Compatibility,and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. Am. J. Hosp. Pharm. 48, 1520-1524.
40. Weiss, R.B., Donehower, R.C., Wiernik, P.H., et al., 1990. Hyper-sensitivity reactions from taxol. J. Clin. Oncol. 8, 1263-1268.
41. Wu, M., Li, H., Li, S., Zeng, J., 2000. The effect of liposome encapsulated daunorubicin on rabbit eyes after extracapsular lens extraction. Eye Sci. 16, 189-193.
42. Totan, Y., Yaǧci, R., Erdurmuş, M., Bayrak, R., Hepşen, I.F., 2008. Cyclosporin effectively inhibits posterior capsule opacification after phacoemulsification in rabbits: a preliminary study. Clin. Exp. Ophthalmol. 36, 62-66. (Pubitemid 351285195)